Food and Drug Administration

4726 Stories, most recent news story added 1 minute ago

Send
- Email
- IM
Share
- Digg
- Facebook
- Newsvine
- del.icio.us
- Reddit
- StumbleUpon
- Technorati
- Yahoo! Bookmarks

St. Jude gets FDA OK for pain treatment device

AP - 6 minutes ago

Medical device maker St. Jude Medical Inc. said Friday the Food and Drug Administration approved a new neurostimulation device aimed at treating pain.

News Stories

Sort By:

AstraZeneca Gets FDA OK For Seroquel XR Add-on
Fox News - Fri Dec 4, 2:48 am ET
AstraZeneca Gets FDA OK For Seroquel XR Add-on
Researchers develop new hepatitis C treatment
AFP via Yahoo! News - Thu Dec 3, 2:25 pm ET
An experimental treatment targeting hepatitis C was able to inhibit replication of the virus in the bloodstream of chimpanzees and could treat chronic infections in humans, a new study said Thursday.
Consumer group seeks Meridia ban
Chicago Tribune - Fri Dec 4, 1:28 am ET
A consumer group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death.
Cubist Pharma rises after upgrade to 'Outperform'
AP via Yahoo! News - Thu Dec 3, 1:42 pm ET
Shares of Cubist Pharmaceuticals Inc. rose Thursday after an analyst upgraded the stock, saying he believes Cubist will successfully defend the patents on its antibiotic Cubicin, and expects sales will remain strong.
US approves AstraZeneca's Seroquel
ShareCast - Fri Dec 4, 2:30 am ET
LONDON (SHARECAST) - The US Food and Drug Administration (FDA) has approved the use of drug giant AstraZeneca ’s bipolar disorder treatment Seroquel in conjunction with antidepressants to treat major depressive disorder (MDD).
AstraZeneca drug wins partial US approval
Newsday - 1 minute ago
AstraZeneca receives partial approval for depression drug from US regulators
Health Highlights: Dec. 3, 2009
HealthDay via Yahoo! News - Thu Dec 3, 12:02 pm ET
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Smoking Exposure Now Linked to Colon, Breast Cancers
HealthDay via Yahoo! News - Thu Dec 3, 12:02 pm ET
THURSDAY, Dec. 3 (HealthDay News) -- Add colorectal cancer to the list of malignancies caused by smoking, with a new study strengthening the link between the two.
U.S. group asks FDA to ban Abbott diet drug
Reuters via Yahoo! News - Thu Dec 3, 11:40 am ET
Abbott Laboratories Inc's weight-loss drug Meridia should be banned immediately because of heart-related risks, a consumer group said on Thursday in a petition to U.S. regulators.
FDA: Hazards found at Cloud's Food Service
The Longview News-Journal - Fri Dec 4, 12:33 am ET
The U.S. Food and Drug Administration warned Longview-based Cloud's Food Service for public health violations its inspectors found this past summer.
Targacept, AstraZeneca cooperate on depression med
AP via Yahoo! News - Thu Dec 3, 10:38 am ET
Targacept Inc. on Thursday struck a deal potentially worth more than $1 billion to develop a depression drugs with AstraZeneca PLC, one of the world's largest drugmakers.
Man wanted in death of toddler is arrested
The Charlotte Observer - 1 hour 54 minutes ago
A 19-year-old man wanted in connection with the death of a 22-month-old girl he was baby-sitting last weekend was arrested Wednesday night, Charlotte-Mecklenburg police said.
Endo says FDA asked for info on Aveed side effects
San Francisco Chronicle - Thu Dec 3, 2:39 pm ET
Endo Pharmaceuticals Holdings Inc. said Thursday regulators want more information about its testosterone injection Aveed as they consider approving the drug for sale. Endo said the FDA sent a complete response letter asking for details about rare but serious... Food and Drug Administration - Drug - Adverse effect - Health - Business
FDA announces Chinese herb recall
UPI - Thu Dec 3, 9:48 am ET
WASHINGTON, Dec. 3 (UPI) -- The U.S. Food and Drug Administration announced the recall of Radix Polygonati Officinalis, a Chinese herb, because of a labeling error.
St. Jude Medical Receives FDA Approval for Industry-First Five-Column Neurostimulation Lead to Manage Chronic Pain
Business Wire via Yahoo! Finance - 29 minutes ago
ST. PAUL, Minn.----St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration approval and U.S. market introduction of its new Penta™ surgical lead for neurostimulation therapy.